Generic dabigatran for cancer-associated venous thromboembolism: Real-world data

被引：0
|
作者：
Saj, F. [1 ]
Dubashi, B. [1 ]
Kayal, S. [1 ]
Ganesan, P. [1 ]
机构：
[1] JIPMER Jawaharlal Inst Postgrad Med Educ & Res, Dept Med Oncol, Pondicherry, India
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.10.318
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
293P
引用
收藏
页码：1545 / 1546
页数：2
相关论文
共 50 条
  • [21] The Epidemiology of Cancer-Associated Venous Thromboembolism: An Update
    Mahajan, Anjlee
    Brunson, Ann
    White, Richard
    Wun, Ted
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2019, 45 (04): : 321 - 325
  • [22] Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
    Raskob, Gary E.
    van Es, Nick
    Verhamme, Peter
    Carrier, Marc
    Di Nisio, Marcello
    Garcia, David
    Grosso, Michael A.
    Kakkar, Ajay K.
    Kovacs, Michael J.
    Mercuri, Michele F.
    Meyer, Guy
    Segers, Annelise
    Shi, Minggao
    Wang, Tzu-Fei
    Yeo, Erik
    Zhang, George
    Zwicker, Jeffrey I.
    Weitz, Jeffrey I.
    Buller, Harry R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (07): : 615 - 624
  • [23] Direct Oral Anticoagulants for the Treatment of Cancer-Associated Venous Thromboembolism in Real-World Clinical Practice - Caution Regarding Substantial Frequency of Bleeding Complications -
    Hosoi, Yutaka
    [J]. CIRCULATION JOURNAL, 2020, 84 (08) : 1232 - 1234
  • [24] Utility of Rivaroxaban for Real-World Patients With Venous Thromboembolism
    Yamashita, Yugo
    [J]. CIRCULATION JOURNAL, 2023, 87 (09) : 1185 - 1186
  • [25] Venous Thromboembolism Risk in Patients With Cancer Receiving Chemotherapy: A Real-World Analysis
    Lyman, Gary H.
    Eckert, Laurent
    Wang, Yanxin
    Wang, Hongwei
    Cohen, Alexander
    [J]. ONCOLOGIST, 2013, 18 (12): : 1321 - 1329
  • [26] Prophylaxis of cancer-associated venous thromboembolism with low-molecular-weight heparin-tinzaparin: Real world evidence
    Christopoulou, Athina
    Ardavanis, Alexandros
    Papandreou, Christos
    Koumakis, Georgios
    Papatsimpas, Georgios
    Papakotoulas, Pavlos
    Tsoukalas, Nikolaos
    Andreadis, Charalambos
    Samelis, Georgios
    Papakostas, Pavlos
    Aravantinos, Gerasimos
    Ziras, Nikolaos
    Souggleri, Maria
    Kalofonos, Charalambos
    Samantas, Epameinondas
    Makrantonakis, Paris
    Pentheroudakis, Georgios
    Athanasiadis, Athanasios
    Stergiou, Helen
    Bokas, Alexandros
    Grivas, Anastasios
    Tripodaki, Elli-Sofia
    Varthalitis, Ioannis
    Timotheadou, Eleni
    Boukovinas, Ioannis
    [J]. ONCOLOGY LETTERS, 2022, 23 (04)
  • [27] Cancer-associated venous Thromboembolism: Edoxaban versus Dalteparin
    Lorenz, Judith
    [J]. TRANSFUSIONSMEDIZIN, 2018, 8 (03) : 137 - 137
  • [28] Update: Anticoagulant Treatment of Cancer-associated Venous Thromboembolism
    Riess, Hanno
    [J]. AKTUELLE KARDIOLOGIE, 2022, 11 (02) : 131 - 135
  • [29] Machine Learning for Prediction of Cancer-Associated Venous Thromboembolism
    Mantha, Simon
    Dunbar, Andrew
    Bolton, Kelly L.
    Devlin, Sean
    Gorenshteyn, Dmitriy
    Donoghue, Mark
    Arcila, Maria E.
    Soff, Gerald A.
    [J]. BLOOD, 2020, 136
  • [30] Clinical controversies in the treatment of cancer-associated venous thromboembolism
    Nachar, Victoria R.
    Schepers, Allison J.
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (04) : 939 - 953
12345